Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prostate Cancer Detected in Blood Using Flow Cytometry

By LabMedica International staff writers
Posted on 22 Feb 2016
Current methods of detecting prostate cancer, such as the prostate-specific antigen (PSA) test and biopsies, have limitations. More...
PSA tests are based on measuring a specific protein released by the prostate gland, but do not provide a definitive diagnosis.

A physical exam and biopsy are needed if PSA levels are elevated; however, even the painful biopsy procedure has a 15% error rate. During biopsies, a painful and invasive procedure, 12 needles are inserted into the rectum, with the hope of extracting material from an area with a tumor.

A team of scientists at the Western University's Schulich School of Medicine and Dentistry (London, ON, Canada) and at Lawson Health Research Institute (London, ON, Canada) have repurposed a machine once used to detect airborne pathogens in the second Gulf War. The machine is now used for fluid biopsies, a noninvasive way to detect prostate microparticles in the blood in a matter of minutes. Microparticles are essentially refuse released by prostate cells that circulate throughout the bloodstream.

The machine was used in the Gulf War, and more commonly to test water purity and the machine uses flow cytometry (Apogee Flow Systems; Hemel Hempstead, UK) to detect microparticles. Flow cytometry measures the specific characteristics of a fluid, such as blood, as it passes through a laser. Most men, who are more than 40 years old, regardless of their health, have detectable levels of prostate microparticles in their bloodstream. The scientists have conducted the first clinical cancer project to correlate the number of microparticles in the blood to the risk of having prostate cancer in that the more microparticles, the higher the risk.

The study provides a more accurate and less invasive testing method for patients suspected of having prostate cancer, and helps to identify patients who are at a higher risk of dying from prostate cancer. Hon Leong, PhD, an assistant professor and team leader, said, “Our findings point to a new direction in how we can better identify patients who actually have prostate cancer. With this test, we can improve the clinical outcomes for patients, reducing costs for unnecessary procedures and reducing errors in diagnosis.”

Related Links:

Western University's Schulich School of Medicine and Dentistry
Lawson Health Research Institute
Apogee Flow Systems



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
ESR Analyzer
TEST1 2.0
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.